Reconnecting

The current page stays visible while onset.to reconnects in the background.

Connection error

onset.to could not restore the live connection within 5 seconds. Reload the page to recover.

Log in

Sources / RSS

Psychedelics Today

RSS

Reporting, essays, and interviews from Psychedelics Today.

psychedelicstoday.com

Most recent Latest added

Most recent Latest added

175 entries

October 3, 2026

Psychedelic Churches Need Psychedelic Seminaries for Meaning, Ministerial Formation, Ethical Oversight, and Accountability

psychedelicstoday.com · Oct 3, 2026 · Paul Ryder, PhD

Essay Education Ethics Spirituality

October 2, 2026

Tell the FDA What Psychedelic Care Should Look Like: Why Chronic Pain Must Be Included Before the Comment Deadline

psychedelicstoday.com · Oct 2, 2026 · Joe Moore

Psilocybin Ketamine Article Clinical +2

Ohio's P.E.A.C.E. Program Trains Emergency Responders to Provide Safer, Supportive Care During Psychedelic Crises

psychedelicstoday.com · Oct 2, 2026 · Sara Gael, MA, LPC

Psilocybin MDMA Article Education +2

September 30, 2026

DEA proposes Schedule I status for five tryptamines as Oregon drops psilocybin fee hikes and GAO questions scheduling procedures

psychedelicstoday.com · Sep 30, 2026 · Jack Gorsline

Psilocybin Article Industry Policy Research

September 22, 2026

FDA hearing, VA psychedelic bill claims, and Alabama's marijuana rescheduling objection shape September 2026 policy briefing

psychedelicstoday.com · Sep 22, 2026 · Jack Gorsline

Psilocybin MDMA Article Industry +2

September 18, 2026

Health Canada authorizes Optimi's natural psilocybin depression trial as a US House bill considers 12-year botanical drug exclusivity

psychedelicstoday.com · Sep 18, 2026 · Jack Gorsline

Psilocybin Article Clinical Industry Policy

September 16, 2026

Lynn Watkins Told the FDA About Chronic Pain, Facilitated Touch, and Psychedelic Delivery, Not the Misattributed Reuters Quote

psychedelicstoday.com · Sep 16, 2026 · Joe Moore

Psilocybin Article Clinical Policy Research

September 11, 2026

Beyond the Foxhole: How Psychedelic Policy Coalitions Are Expanding From Veterans to First Responders Nationwide

psychedelicstoday.com · Sep 11, 2026 · Logan Davidson

Psilocybin Ibogaine Essay Community +2

September 10, 2026

THE GATEWAY: Live From DC After the FDA Psychedelics Hearing Brings the Field Together in Silver Spring

psychedelicstoday.com · Sep 10, 2026 · Psychedelics Today

Article Community Events Policy

August 28, 2026

Why the Most Effective Psychedelic Education Begins in Trusted Cultural Spaces, Not Clinical Settings

psychedelicstoday.com · Aug 28, 2026 · Devon Phillips

Essay Culture Education HarmReduction

August 25, 2026

Who Gets to Heal? Meredith Thomas Questions Whether Psychedelic Access Should Require a Diagnosis

psychedelicstoday.com · Aug 25, 2026 · Meredith Thomas

Psilocybin Ayahuasca Article Community +2

August 24, 2026

Oregon Psilocybin Data, Heidi Overton’s FDA Nomination, and Johnson & Johnson’s $85 Million Delix Investment

psychedelicstoday.com · Aug 24, 2026 · Jack Gorsline

Psilocybin 5-MeO-DMT Article Industry +2

August 19, 2026

Horizons Perspectives on Psychedelics gathers clinicians, researchers, entrepreneurs, and cultural voices to examine therapy, policy, business, and the future of psychedelic medicine

psychedelicstoday.com · Aug 19, 2026 · Psychedelics Today

Events Research Therapy

August 18, 2026

MDMA NDA resubmission returns to the FDA in August 2026 as sponsors seek renewed review after prior setback in the US drug approval process

psychedelicstoday.com · Aug 18, 2026 · Psychedelics Today

MDMA Article Industry Policy Therapy

August 14, 2026

Perimenopause and psychedelic research converge around hormonal change, mood symptoms, and the need for more targeted studies on treatment, safety, and lived experience

psychedelicstoday.com · Aug 14, 2026 · Psychedelics Today

Article Clinical Research Therapy

August 12, 2026

Post-psychedelic challenges center on lasting psychological difficulties, integration gaps, and the need for clearer support after intense nonordinary states

psychedelicstoday.com · Aug 12, 2026 · Psychedelics Today

Article HarmReduction Integration Safety

August 10, 2026

Psychedelic policy developments on August 9, 2026 span regulation, access, and legal change across jurisdictions as lawmakers and agencies reshape the field

psychedelicstoday.com · Aug 10, 2026 · Psychedelics Today

Industry Mainstream Policy

Gabon places ibogaine policy within national sovereignty, cultural stewardship, and global demand as international interest in iboga-derived medicine accelerates

psychedelicstoday.com · Aug 10, 2026 · Psychedelics Today

Ibogaine Article Ethics Ethnobotany Policy

August 6, 2026

Post-psychedelic challenges include anxiety, confusion, social disruption, and functional impairment, with support needs shaped by setting, intensity, and aftercare gaps

psychedelicstoday.com · Aug 6, 2026 · Psychedelics Today

Integration Research Safety

August 5, 2026

DanceSafe receives glassware from the Shulgin lab, linking psychedelic chemistry history to present-day drug checking and harm reduction practice

psychedelicstoday.com · Aug 5, 2026 · Psychedelics Today

Community HarmReduction History

August 3, 2026

Psychedelic policy developments on August 3, 2026 track legal, regulatory, and institutional shifts affecting access, oversight, and public debate

psychedelicstoday.com · Aug 3, 2026 · Psychedelics Today

Industry Mainstream Policy

July 31, 2026

Mareesa Stertz verbindet in Sphinx Gate Burning-Man-Kunst, immersive Architektur und bewusstseinsbezogene Erfahrung zu einem gemeinschaftlichen Ritualraum

psychedelicstoday.com · Jul 31, 2026 · Psychedelics Today

Art Community Consciousness DE

July 30, 2026

Psilocybin trial for military veterans with PTSD highlights clinical interest in psychedelic-assisted treatment and the challenges of study design and access

psychedelicstoday.com · Jul 30, 2026 · Psychedelics Today

Psilocybin Clinical Research Therapy

Psychedelic policy developments in late July 2026 track legislative, regulatory, and legal shifts affecting access, research, decriminalization, and state programs

psychedelicstoday.com · Jul 30, 2026 · Psychedelics Today

Mainstream Policy Research

July 23, 2026

Chinese medicine and psychedelics intersect through diagnosis, embodiment, and long term healing beyond symptom relief alone

psychedelicstoday.com · Jul 23, 2026 · Psychedelics Today

Article Culture Integration Therapy